Specific References (6) | SL1743R has been referenced in 6 publications.
[IF=6.05] Andrew Kisling. et al. Loss of Function in Dopamine D3 Receptor Attenuates Left Ventricular Cardiac Fibroblast Migration and Proliferation in vitro. Front Cardiovasc Med. 2021; 8: 732282 IF ; Mouse.
[IF=2.35] Xu, Jiao-jiao, et al. "Dopamine D1 receptor activation induces dehydroepiandrosterone sulfotransferase (SULT2A1) in HepG2 cells." Acta Pharmacologica Sinica (2014). WB ; Human.
[IF=4.432] Ting Li. et al. Rotigotine-loaded microspheres exerts the antinociceptive effect via central dopaminergic system. Eur J Pharmacol. 2021 Nov;910:174443 WB ; Rat.
[IF=4.831] Shi L et al. Clioquinol improves motor and non-motor deficits in MPTP-induced monkey model of Parkinson's disease through AKT/mTOR pathway. Aging (Albany NY)
. 2020 May 18;12(10):9515-9533. WB ; Monkey.
[IF=5.108] Yang K et al. Synaptic dopamine release is positively regulated by SNAP-25 that involves in benzo [a] pyrene-induced neurotoxicity. Chemosphere. 2019 Jul 15;237:124378. IHSLCP,ICF&WB ; Rat.
[IF=4.181] Bai L et al. m6A demethylase FTO regulates dopaminergic neurotransmission deficits caused by arsenite.Toxicol Sci. 2018 Oct 1;165(2):431-446. WB ; Mouse.